Contract 75A50124F61010
Glaxosmithkline, Llc · Department Of Health And Human Services · February 20, 2024
Glaxosmithkline, Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on February 20, 2024 for $41.01 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Durham, NC. This is a task or delivery order issued under parent IDIQ 75A50122D00002. The contract has been modified 20 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 31, 2026.
Contract details
- PIID
- 75A50124F61010
- Parent IDIQ
- 75A50122D00002
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; R&D Administrative Expenses
- Place of performance
- Durham, NC
- First action
- February 20, 2024
- Latest action
- March 31, 2026
Description
THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002.
Modification timeline
-
March 31, 2026Mod P00009THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES U$2.72M
-
November 20, 2025Mod P00008THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES U$16.2K
-
September 17, 2025Mod P00007THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES$24.4K
-
June 24, 2025Mod P00006THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES$15.3K
-
May 6, 2025Mod P00005THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND$2.17M
-
April 18, 2025Mod P00006SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND RESPONSE, UND$0
-
April 10, 2025Mod P00003THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE SERVICES UNDER THE ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREP$0
-
February 19, 2025Mod P00004THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND$0
-
January 17, 2025Mod P00002THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE SERVICES UNDER THE ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREP$0
-
January 8, 2025Mod P00005SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND RESPONSE, UND$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| The Broad Institute, Inc | Department Of Health And Human Services | March 30, 2026 | $29.62M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124F61010?
Contract 75A50124F61010 is a federal contract awarded to Glaxosmithkline, Llc by Department Of Health And Human Services on February 20, 2024 for $41.01 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 20 times since the base award.
Who won contract 75A50124F61010?
Glaxosmithkline, Llc won contract 75A50124F61010 from Department Of Health And Human Services.
How much is contract 75A50124F61010 worth?
Contract 75A50124F61010 has obligated $41.01 million to date.